Pink Sheet Podcast: How Will Trump’s Second Term Impact The US FDA?

 
• By Derrick Gingery, Sarah Karlin-Smith, and Nielsen Hobbs

Pink Sheet reporter and editors discuss potential changes that the incoming Trump Administration could make to the FDA, as well as worries about political interference in decision-making, and policy and staffing changes.

Pink Sheet podcast
Will Trump reshape the FDA during his second term? • Source: Citeline/Shutterstock

More from Elections

More from Agency Leadership